We aim to test how attention exerts its facilitative effects on perception. We expect a validation of the *pulsed inhibition* theory, i.e., that - for an unattended location - perceptual probability is normal during the excitatory phase but…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
nvt
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
We aim to determine the relation between the amplitude of alpha oscillations
and the effect of their phase on visual cortical excitability and phosphene
probability. We expect the validation of the *pulsed inhibition theory*
postulating that perception is only decreased during the inhibitory phase of
the alpha oscillation.
Secondary outcome
In addition to the assessment of visual cortical excitability and perception by
means of phosphene probability, the amplitude of simultaneously recorded TEPs
will be employed as an additional measure of phase-dependent cortical
excitability (Bergmann et al., 2012).
Background summary
Over the occipital region, shifts in covert visuospatial attention are
associated with a lateralization of posterior alpha band power (8-14 Hz). Alpha
power is higher in the hemisphere ipsilateral to attention (Jensen and
Mazaheri, 2010). Recently, Transcranial Magnetic Stimulation (TMS) has been
used to causally link ongoing oscillations, cortical excitability and visual
perception. Thus, we know that over the occipital region, alpha power is
negatively related to cortical excitability (Romei et al., 2008) but also that
alpha phase mediates the causal relation between brain excitation and visual
perception (Dugué et al., 2011). Using attention to modulate ongoing alpha
amplitude, we aim to determine how the phase effect behaves depending on alpha
power (i.e., depending on attention). In particular, a stronger phase effect is
expected for the unattended condition.
Study objective
We aim to test how attention exerts its facilitative effects on perception. We
expect a validation of the *pulsed inhibition* theory, i.e., that - for an
unattended location - perceptual probability is normal during the excitatory
phase but decreased during the inhibitory phase of the alpha oscillation.
Study design
This study will combine TMS with EEG. Two TMS coils will be positioned over the
left and right primary visual cortex (V1) to induce phosphenes (illusory
flashes) by single pulses. For both target areas, TMS intensity will be set to
phosphene threshold (i.e., evoking phosphenes in 50% of the cases). Subject
will perform two tasks, intermingled on a trial-by-trial level: a Gabor
orientation task (determining the orientation of a tilted Gabor patch in the
cued hemifield) and a phosphene localization task (perceiving and localizing a
TMS-induced phosphenes in the left or right hemifield). The Gabor spatial
attention task is used to warrant that subjects covertly orient their attention
to the cued hemifield and allows us to test phosphene probability depending on
alpha power as modulated by visuospatial attention.
Intervention
Participants will receive single pulses of TMS over left or right V1 at the
individual subject*s and target site*s phosphene threshold.
Study burden and risks
TMS of the visual cortex is not painful, even at maximum stimulator output.
From the literature we know that, in rare cases, participants could report a
(light) headache. Paracetamol is sufficient to treat these symptoms. On the
basis of incidental epileptic seizures triggered by TMS in early 90*s,
safety-guidelines were established (Wassermann, 1998) and recently updated
(Rossi et al., 2009). All stimulation parameters in this study will follow
these safety guidelines. Furthermore, all participants will be pre-screened for
relevant medical history, epilepsy, drug abuse, head trauma, neurological or
psychiatric illness, pregnancy, heart disease, cardiac pacemakers, medication
pumps, tricyclic antidepressants, neuroleptics and a family history of
neurological illness, psychiatric illness or epilepsy. Because the risk
associated with participation can be considered negligible and the burden can
be considered minimal, we do not expect adverse events during the project.
Kapittelweg 29
6525EN Nijmegen
NL
Kapittelweg 29
6525EN Nijmegen
NL
Listed location countries
Age
Inclusion criteria
- 18-45 years old
- Right-handed
- Normal or corrected-to-normal vision
- No history of mental or psychological disorders
Exclusion criteria
- Pacemaker or (history of) heart rhythm disorder
- Metal parts in head or mouth*
- History of brain surgery
- History of epilepsy or first-grade family member with epilepsy
- Psychological or neurological disorder
- Skin allergies
- Pregnancy
- Prescription medication
- Being treated or having recently been treated by a medical specialist.
* with the exception of a wire behind the teeth.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL39390.091.12 |